Related Experiment Video
Updated: Aug 5, 2026

Mass Production of Genetically Modified Aedes aegypti for Field Releases in Brazil
Published on: January 4, 2014
Deltamethrin resistance in Aedes aegypti results in treatment failure in Merida, Mexico
Gonzalo M Vazquez-Prokopec1, Anuar Medina-Barreiro2, Azael Che-Mendoza3
1Department of Environmental Sciences, Emory University, Atlanta, Georgia, United States of America.
Abstract:
The operational impact of deltamethrin resistance on the efficacy of indoor insecticide applications to control Aedes aegypti was evaluated in Merida, Mexico. A randomized controlled trial quantified the efficacy of indoor residual spraying (IRS) against adult Ae. aegypti in houses treated with either deltamethrin (to which local Ae. aegypti expressed a high degree of resistance) or bendiocarb (to which local Ae. aegypti were fully susceptible) as compared to untreated control houses. All adult Ae. aegypti infestation indices during 3 months post-spraying were significantly lower in houses treated with bendiocarb compared to untreated houses (odds ratio <0.75; incidence rate ratio < 0.65) whereas no statistically significant difference was detected between the untreated and the deltamethrin-treated houses. On average, bendiocarb spraying reduced Ae. aegypti abundance by 60% during a 3-month period. Results demonstrate that vector control efficacy can be significantly compromised when the insecticide resistance status of Ae. aegypti populations is not taken into consideration.
More Related Videos
Related Concept Videos
Rocky Mountain Spotted Fever
Anthelminthic Agents

